Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer

por Halvorsen, Tarje Onsøien, Valan, Christine Damgaard, Slaaen, Marit, Grønberg, Bjørn Henning
Publicado 2020

Associations between severe co‐morbidity and muscle measures in advanced non‐small cell lung cancer patients

por Grønberg, Bjørn H., Valan, Christine Damgaard, Halvorsen, Tarje, Sjøblom, Bjørg, Jordhøy, Marit S.
Publicado 2019

Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018

por Graabak, Gustav, Grønberg, Bjørn Henning, Sandvei, Marie Søfteland, Nilssen, Yngvar, Halvorsen, Tarje Onsøien
Publicado 2021

Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer

por Stokke, Kristin, Sandvei, Marie Søfteland, Grønberg, Bjørn Henning, Slaaen, Marit, Killingberg, Kristin T, Halvorsen, Tarje O
Publicado 2022

Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC

por Stokke, Kristin, Halvorsen, Tarje Onsøien, Grønberg, Bjørn Henning, Saltvedt, Ingvild, Slaaen, Marit, Kirkevold, Øyvind, Killingberg, Kristin Toftaker, Sandvei, Marie Søfteland
Publicado 2022

Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer

por Ottestad, Anine Larsen, Johansen, Håkon, Halvorsen, Tarje Onsøien, Dai, Hong Yan, Wahl, Sissel Gyrid Freim, Emdal, Elisabeth Fritzke, Grønberg, Bjørn Henning
Publicado 2023

Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer

por Ottestad, Anine Larsen, Johansen, Håkon, Halvorsen, Tarje Onsøien, Dai, Hong Yan, Wahl, Sissel Gyrid Freim, Emdal, Elisabeth Fritzke, Grønberg, Bjørn Henning
Publicado 2023

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy

por Wahl, Sissel Gyrid Freim, Dai, Hong Yan, Emdal, Elisabeth F, Ottestad, Anine L, Dale, Vibeke G, Richardsen, Elin, Halvorsen, Tarje O, Grønberg, Bjørn Henning
Publicado 2021

Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial

por Horndalsveen, Henrik, Alver, Tine Norman, Dalsgaard, Astrid Marie, Rogg, Lotte Victoria, Helbekkmo, Nina, Grønberg, Bjørn Henning, Halvorsen, Tarje Onsøien, Ramberg, Christina, Haakensen, Vilde Drageset, Öjlert, Åsa Kristina, Bjaanæs, Maria Moksnes, Helland, Åslaug
Publicado 2022

The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study

por Wahl, Sissel Gyrid Freim, Dai, Hong Yan, Emdal, Elisabeth Fritzke, Berg, Thomas, Halvorsen, Tarje Onsøien, Ottestad, Anine Larsen, Lund-Iversen, Marius, Brustugun, Odd Terje, Førde, Dagny, Paulsen, Erna-Elise, Donnem, Tom, Andersen, Sigve, Grønberg, Bjørn Henning, Richardsen, Elin
Publicado 2021